We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-0.44%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
-$108M
Cap. Flow %
-7.65%
Top 10 Hldgs %
40.58%
Holding
226
New
9
Increased
48
Reduced
78
Closed
10

Top Buys

Rank Stock Value
1
SO icon
Southern Company
SO
+$3.36M
2
PCOR icon
Procore
PCOR
+$1.51M
3
TJX icon
TJX Companies
TJX
+$1.37M
4
HD icon
Home Depot
HD
+$1.2M
5
HPQ icon
HP
HPQ
+$1.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$45.4M
2
WMT icon
Walmart Inc
WMT
+$20.5M
3
WST icon
West Pharmaceutical
WST
+$9.83M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.45M
5
TSLA icon
Tesla
TSLA
+$4.67M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 17.13%
3 Consumer Staples 16.22%
4 Healthcare 10.07%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FMC icon
151
FMC
FMC
$1.3B
$610K 0.04%
14,448
– –
NVO
152
Novo Nordisk
NVO
$196B
$602K 0.04%
8,675
– –
TTWO icon
153
Take-Two Interactive
TTWO
$44.9B
$601K 0.04%
2,900
– –
DOW icon
154
Dow Inc
DOW
$21.6B
$594K 0.04%
17,022
-2,750
-14% -$106K
CARR icon
155
Carrier Global
CARR
$52.1B
$571K 0.04%
9,000
-500
-5% -$33.2K
CARG icon
156
CarGurus
CARG
$3.33B
$565K 0.04%
19,400
– –
LDOS icon
157
Leidos
LDOS
$14.9B
$540K 0.04%
4,000
– –
NVS icon
158
Novartis
NVS
$292B
$524K 0.04%
4,700
– –
CSX icon
159
CSX Corp
CSX
$92.3B
$518K 0.04%
17,600
– –
VRT icon
160
Vertiv
VRT
$104B
$507K 0.04%
+7,022
New +$747K
MET icon
161
MetLife
MET
$62B
$501K 0.04%
6,244
-68
-1% -$5.66K
MMM icon
162
3M
MMM
$91.4B
$499K 0.04%
3,400
-1,500
-31% -$220K
BIDU icon
163
Baidu
BIDU
$38.2B
$497K 0.04%
5,400
– –
AMD icon
164
Advanced Micro Devices
AMD
$846B
$495K 0.04%
4,819
– –
MKC icon
165
McCormick & Company Non-Voting
MKC
$13.9B
$494K 0.03%
6,000
– –
QQQ icon
166
Invesco QQQ Trust
QQQ
$485B
$489K 0.03%
1,043
– –
PBR icon
167
Petrobras
PBR
$123B
$476K 0.03%
33,200
– –
ROST icon
168
Ross Stores
ROST
$81.1B
$443K 0.03%
3,467
-200
-5% -$28K
GEV icon
169
GE Vernova
GEV
$271B
$442K 0.03%
1,448
-352
-20% -$123K
PAGP icon
170
Plains GP Holdings
PAGP
$5.15B
$427K 0.03%
20,000
– –
WSM icon
171
Williams-Sonoma
WSM
$28.2B
$427K 0.03%
2,700
-22,700
-89% -$4.39M
ZTS icon
172
Zoetis
ZTS
$31.9B
$412K 0.03%
2,500
-2,400
-49% -$399K
MCHP icon
173
Microchip Technology
MCHP
$43.8B
$411K 0.03%
8,500
-2,400
-22% -$134K
HII icon
174
Huntington Ingalls Industries
HII
$12.8B
$408K 0.03%
2,000
– –
HUM icon
175
Humana
HUM
$45B
$404K 0.03%
1,525
– –
5 6
7
8 9

Similar funds

MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return

Cullinan Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Cullinan Associates held 226 positions worth $1.41B, down 9.2% from $1.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cullinan Associates withdrew a net $108M in Q1 2025, closing 10 positions and reducing 78 holdings. Its most notable exit was West Pharmaceutical, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Cullinan Associates opened a new position in Procore worth $1.32M.

  • Cullinan Associates's largest Q1 2025 buy was Procore: 20,000 shares worth $1.32M.
  • Cullinan Associates added most to Southern Company in Q1 2025, an estimated $3.36M increase.
  • Cullinan Associates's biggest Q1 2025 reduction was Apple, cutting an estimated $45.4M.
  • Cullinan Associates fully exited West Pharmaceutical in Q1 2025, selling an estimated $9.83M.
  • Cullinan Associates's ten largest holdings make up 41% of its $1.41B portfolio in Q1 2025.
  • Cullinan Associates opened 9 new positions and closed 10 in Q1 2025.
  • Cullinan Associates's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Cullinan Associates's 13F filing for Q1 2025, filed 22 Apr 2025.